88IV - PR Newswire Asia's news - Health Care/Hospital

< Previous page

| Title only | Print

Next page >

Global Study Results Published in Aesthetic Surgery Journal Open Forum Show Link Between Self-Confidence and Aesthetics Publication in the peer-reviewed journal reinforces the study's insights and validates what clinicians frequently observe – that the impact of aesthetic treatments extends beyond physical appearance. ... 2026-08-11T Cosmetics & Personal Care Health Care/Hospital Household/Consumer/Cosmetics Medical/Pharmaceuticals
Aureka Biotechnologies Raises US$100 Million Series B to Build a Biological World Model for Drug Discovery LAGUNA HILLS, Calif. and SHANGHAI , Aug. 11, 2026 /PRNewswire/ -- Aureka Biotechnologies announced the close of a US$100 million Series B financing on Aug. 10, 2026. Granite Asia funded the first ... 2026-08-11T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Lifespan Vision Ventures Leads Remedium Bio's Series A Financing Investment supports advancement of Remedium's durable protein therapeutics platform toward first-in-human clinical development. ... 2026-08-10T Banking/Financial Service Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Unveiling a Smarter Future for Dentistry at China Dental Show 2026 AI-powered clinical solutions, hands-on experiences and global business opportunities will come together in Shanghai from October 13 to 16 ... 2026-08-10T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
POMDOCTOR LIMITED Highlights Healthcare Intelligence Flywheel as a Self-Reinforcing Growth Engine GUANGZHOU, China , Aug. 10, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled ... 2026-08-10T Computer/Electronics Consumer Electronics Health Care/Hospital Medical Equipment
Ascletis Announces Initiation of Two Phase I Studies in U.S. for the Treatment of Obesity: ASC36 Once-Monthly Injection, an Amylin Receptor Peptide Agonist, and ASC36_35FDC Once-Monthly Injection, a Co-Formulation of ASC36 and GLP-1R/GIPR Peptide Agonist ASC35 -ASC36_35FDC, a once-monthly subcutaneous (SQ) fixed dose combination (FDC) injection of ASC36 and ASC35, is a potentially first-in-class drug candidate which targets three validated targets of amylin ... 2026-08-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Dx&Vx Signs Two Material Transfer Agreements in Latin America Within Two Months -- "Technology Validated Across Both Public and Private Sectors" — Argentine biopharmaceutical company in July, South American public health institution in August sign consecutive KRNA material transfer agreements — Two of five cumulative MTAs now in Latin America, ... 2026-08-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
New ReSound Sensia™ hearing aids lift the voice you want to hear - not just the loudest Automatically, accurately, proven. ... 2026-08-10T Consumer Electronics Electronic Components Health Care/Hospital Medical Equipment
Akeso Advances IO2.0 + ADC2.0 Strategy: First Patient Dosed in Phase II Study of TROP2/Nectin-4 Bispecific ADC (AK146D1) Combined with Ivonescimab in Breast Cancer HONG KONG , Aug. 10, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase II clinical study (AK146D1-202) ... 2026-08-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
/C O R R E C T I O N -- United Imaging/ In the news release, Chinese and Indonesian cardiologists complete Southeast Asia's first "noise-free" cardiac procedure in Jakarta, issued 09-Aug-2026 by United Imaging over PR Newswire, the ... 2026-08-10T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved